Healio
Healio
Metastatic Breast Cancer Cells

SABCS Video Perspectives

Healio spoke with experts in breast cancer about what to expect from SABCS 2019, developments in diagnosis, advances in treatments, pivotal trials and more highlights from the meeting.

Choose a Section
  • Virginia Kaklamani, MD, DSc
  • C. Kent Osborne, MD
  • Carlos Arteaga, MD

    • C. Kent Osborne, MD

    C. Kent Osborne, MD, is the director of the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine and co-director of the San Antonio Breast Cancer Symposium.

    In this video, Osborne discusses:

    • developments in breast cancer detection with circulating tumor DNA;
    • novel drugs that have the potential to change routine practice for HER2-positive breast cancer;
    • major advances in triple negative breast cancer;
    • pivotal trials in breast cancer prevention; and
    • the main takeaways from SABCS 2019.

    Read more about

    metastatic breast cancer
    breast cancer
    her2-positive breast cancer
    You've successfully added to your alerts. You will receive an email when new content is published.

    Click Here to Manage Email Alerts

    We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.